Want to create an interactive transcript for this episode?
Podcast: Tradeoffs
Episode: The Aducanumab Aftermath: The Patient
Description: Desperate to slow her cognitive decline, one patient shares her hopes and concerns about the first new Alzheimer’s drug in nearly 20 years.This episode is part of a special weeklong series examining the potentially sweeping consequences this drug, known as aducanumab, could have on millions of patients’ lives and billions of dollars in health care spending.Guest: Arthena Caston, Alzheimer’s patient and advocateExplore the full series and additional resources: https://tradeoffs.org/aducanumabRead a transcript of this episode: https://tradeoffs.org/2021/06/23/the-aducanumab-aftermath-the-patient/Sig...